FDA adds cannabis products to adverse event reporting form (Newsletter: October 1, 2025)

*WI GOP medical marijuana bill; German gov’t legalization report; Alcohol
industry group welcomes THC hemp drink maker; Roger Stone on Trump &
cannabis*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*Free to read (but not free to produce)!* We’re proud of our newsletter and
the reporting we publish at Marijuana Moment, and we’re happy to provide it
for free. But it takes a lot of work and resources to make this happen.

If you value Marijuana Moment, invest in our success on Patreon so we can
expand our coverage and more readers can benefit:
https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

The Food and Drug Administration has added “Cannabinoid Hemp Products (such
as products containing CBD)” as a selectable option on adverse event
reporting forms in order to better track the health impacts of increasingly
popular hemp-derived consumables.

Wisconsin’s Republican Senate president joined other GOP lawmakers in
filing legislation to legalize medical cannabis—saying that “someone who
suffers from a serious health condition should not have to make the choice
to travel to another state or break the law.”

A new report from the German Ministry of Health shows that the country’s
marijuana legalization law has not led to an increase in youth use or
cannabis-related traffic accidents—though its limited rollout has not yet
significantly displaced the illicit market.

Republican political operative Roger Stone said President Donald Trump can
outdo Democrats by rescheduling marijuana—claiming that members of the
other party “always talk about” cannabis but “did nothing” when they
controlled the White House and Congress.

- “I pray that President Trump will make a very different decision.”

Wine & Spirits Wholesalers of America added a company that makes
THC-infused drinks to its membership roster for the first time, with
CannaBuzz joining as an associate member.

The Michigan Cannabis Industry Association is considering filing a lawsuit
to challenge a marijuana tax increase that’s advancing in the legislature,
saying it failed to reach a three-fourths majority vote threshold needed to
amend voter-approved initiatives.

*/ FEDERAL*

The White House Office of National Drug Control Policy is moving to
recompete awards for the Drug-Free Communities grants program.

The U.S. Court of Appeals for the Tenth Circuit is allowing a prosecution
to proceed against an Oklahoma lawyer who allegedly helped clients
circumvent residency requirements for medical cannabis businesses.

The Congressional Research Service noted a recent U.S. Court of Appeals for
the Tenth Circuit ruling on marijuana consumers’ gun rights.

*/ STATES*

The Nebraska attorney general’s office sent cease and desist letters to
every retailer in the state that is allegedly illegally selling synthetic
THC-containing products.

A U.S. Virgin Islands judge ruled that police may not use the smell of
marijuana alone as probable cause for vehicle searches.

Vermont regulators posted guidance on cannabis testing lab action limits.

Iowa regulators published guidance on consumable hemp products.

California regulators posted a report on cannabis business tax deductions.

Michigan regulators announced a consent order and stipulation with a
marijuana business that will result in it surrendering its license as a
result of alleged violations.

The North Carolina Advisory Council on Cannabis met.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ LOCAL*

Burlington, Vermont officials are looking for a location to house a
state-funded safe consumption site for illegal drugs.

*/ INTERNATIONAL*

Uruguayan officials are moving to include CBD in the national therapeutic
formulary.

South Africa’s Agricultural Research Council is preparing to build a
cannabis research facility.

*/ SCIENCE & HEALTH*

A study suggested that a “CBD–mupirocin formulation holds considerable
promise for clinical application in the management of skin infections
caused by resistant S. aureus strains.”

A study found that “cannabidiol prevents cognitive and social deficits in a
male rat model of Alzheimer’s disease through CB1 activation and
inflammation modulation.”

*/ ADVOCACY, OPINION & ANALYSIS*

MSNBC host Lawrence O’Donnell suggested that President Donald Trump may
have been high on marijuana when he posted a “goofy” video about the
medical benefits of cannabis.

*/ BUSINESS*

Curaleaf, Inc. is being sued by a former employee over alleged “systemic
diversion” of cannabis products.

Simplifya raised $2 million in new equity capital.

Ascend Wellness Holdings, Inc. entered into and closed a $9.3 million
secured financing transaction pursuant to which it mortgaged real estate on
three properties in Ohio.

Flowhub launched a new marketing suite product for dispensaries.

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

The post FDA adds cannabis products to adverse event reporting form
(Newsletter: October 1, 2025) appeared first on Marijuana Moment.